RNA Aptamers that Differentiate Among HIV-1 Capsid Assembly States
RNA Aptamers that Differentiate Among HIV-1 Capsid Assembly States
批准号:
9303240
负责人:
Donald H Burke
金额:
$23.03万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-06-24 至 2019-05-31
关键词:
Antiviral AgentsBindingBinding SitesBioinformaticsBiologicalBiologyCapsidCapsid ProteinsCellsConeDefectDimerizationDissociationElementsEnzymesEquilibriumEventFullerenesFutureGenetic MaterialsHIVHIV-1HealthImmune responseIn VitroIntegration Host FactorsInvestigationLeadLife Cycle StagesLinkMediatingMethodsMutationNatural ImmunityNuclear ImportPeptide HydrolasesPharmaceutical PreparationsProcessProteinsPublic HealthRNAResearchReverse TranscriptionRoleSiteSolventsStructureSurfaceViralViral PathogenesisVirusVirus ReplicationWorkaptamerdimerexperimental studygag Gene Productsin vivosmall moleculestructural biologytoolvirus genetics
中文摘要
项目摘要
成熟的HIV-1衣壳核心因其在HIV感染性中的关键作用而成为关键的抗病毒靶点
以及发现衣壳特异的寄主限制因子,如TRIM5α和MX2。最近的工作有
证明衣壳不只是存放病毒遗传物质,还需要
复制酶。它还参与并可以调解几个关键复制事件,
包括脱壳、启动反转录、核导入、整合和逃避宿主免疫
回应。对于这些过程中的每一个,衣壳的稳定性和解离之间的微妙平衡
必须保持,证明衣壳和病毒传染性之间存在复杂的联系。
成熟的衣壳格子是在蛋白酶介导的Gag多聚蛋白被切割后形成的。最基本的
成熟晶格的结构元件是衣壳蛋白(CA)六聚体,由CA二聚体三聚体组成。
富勒烯锥体结构包含约250个六角体,以及12个五聚体,以便于关闭。突变
改变衣壳蛋白(CA)组装状态的相对稳定性(二聚体、五聚体、六聚体或
组装的晶格)由于一个或多个复制事件的中断而导致严重的传染性缺陷。
复制也可以通过宿主因子结合的改变而受到影响。值得注意的是,CA在
这些事件并未得到很好的理解,也不清楚各种CA程序集状态如何促成
衣壳的功能或与复制中涉及的宿主因子的相互作用。目前还没有工具可用于
区分体内的CA组装状态,以评估它们在复制事件中的作用。这个项目将
鉴定和鉴定与组装的六聚体晶格特异结合位点的RNA适配子,并
通过绑定到独特的暴露于溶剂的缝隙来区分CA组装状态,这些缝隙定义
每个独立的CA程序集状态。拟议中的实验充分利用了研究小组的
多靶标适体选择方面的专业知识,选择后生物信息学分析的进展,细胞内
适配子表达、艾滋病毒生物学和先天免疫。重要的是,拟议的方法可以广泛应用
适用于其他对公众健康有重要影响的病毒。
英文摘要
Project Summary
The mature HIV-1 capsid core has emerged as a key antiviral target because of its critical role in HIV infectivity
and the discovery of capsid-specific host restriction factors, such as TRIM5α and MX2. Recent work has
demonstrated that capsid does much more than simply house the viral genetic material and required
replication enzymes. It also participates in and may mediate several critical replication events,
including uncoating, initiation of reverse transcription, nuclear import, integration, and evasion of host immune
responses. For each of these processes to occur, a delicate balance between capsid stability and dissociation
must be maintained, demonstrating an intricate link between capsid and viral infectivity.
The mature capsid lattice is formed following protease-mediated cleavage of the Gag polyprotein. The basic
structural element of the mature lattice is a capsid protein (CA) hexamer, comprising a trimer of CA dimers.
The fullerene cone structure contains ~250 hexamers, along with 12 pentamers to facilitate closing. Mutations
that alter the relative stability of capsid protein (CA) assembly states (dimers, pentamers, hexamers, or the
assembled lattice) result in severe infectivity defects due to disruption of one or more replication events.
Replication can also be impacted through alteration of host factor binding. Notably, the specific roles of CA in
these events is not well understood, and it is unknown how the various CA assembly states contribute to
capsid function or interactions with host factors involved in replication. There are currently no tools available to
differentiate CA assembly states in vivo to assess their role during replication events. This project will
identify and characterize RNA aptamers that bind sites specific to the assembled hexamer lattice and
differentiate among CA assembly states by binding to unique solvent-exposed crevices that define
each independent CA assembly state. The proposed experiments capitalize on the research team's
expertise in poly-target aptamer selection, advances in post-selection bioinformatics analysis, intracellular
aptamer expression, HIV biology, and innate immunity. Importantly, the proposed approach could be widely
applicable to other viruses of importance to public health.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
GS-CA Compounds: First-In-Class HIV-1 Capsid Inhibitors Covering Multiple Grounds.
GS-CA 化合物:涵盖多种领域的一流 HIV-1 衣壳抑制剂。
DOI:
10.3389/fmicb.2019.01227
发表时间:
2019
期刊:
Frontiers in microbiology
影响因子:
5.2
作者:
[Singh,Kamal, Gallazzi,Fabio, Hill,KyleJ, Burke,DonaldH, Lange,MargaretJ, Quinn,ThomasP, Neogi,Ujjwal, Sönnerborg,Anders]
通讯作者:
Sönnerborg,Anders
Mechanism of Microbial DNA Hypervariation through Mutagenic Transposition
-
批准号:10221727
-
项目类别:
-
资助金额:$28.86万
-
财政年份:2018
-
负责人:Donald H Burke
-
依托单位:
Mechanism of Microbial DNA Hypervariation through Mutagenic Transposition
-
批准号:9788497
-
项目类别:
-
资助金额:$28.88万
-
财政年份:2018
-
负责人:Donald H Burke
-
依托单位:
Mechanism of Microbial DNA Hypervariation through Mutagenic Transposition
-
批准号:10387714
-
项目类别:
-
资助金额:$9.21万
-
财政年份:2018
-
负责人:Donald H Burke
-
依托单位:
Strain-specific and pan-filoviral aptamer recognition of Ebola virus glycoproteins
-
批准号:9293978
-
项目类别:
-
资助金额:$23.98万
-
财政年份:2016
-
负责人:Donald H Burke
-
依托单位:
Strain-specific and pan-filoviral aptamer recognition of Ebola virus glycoproteins
-
批准号:9181298
-
项目类别:
-
资助金额:$18.76万
-
财政年份:2016
-
负责人:Donald H Burke
-
依托单位:
EVALUATION OF CANDIDATE VACCINE TECHNOLOGIES USING AGENT BASED COMPUTATIONAL ME
-
批准号:8171787
-
项目类别:
-
资助金额:$0.11万
-
财政年份:2010
-
负责人:Donald H Burke
-
依托单位:
EVALUATION OF CANDIDATE VACCINE TECHNOLOGIES USING AGENT BASED COMPUTATIONAL ME
-
批准号:7956315
-
项目类别:
-
资助金额:$0.08万
-
财政年份:2009
-
负责人:Donald H Burke
-
依托单位:
Determinates of anti-HIV nucleic acid aptamer potency and resistance
-
批准号:7924282
-
项目类别:
-
资助金额:$6.08万
-
财政年份:2009
-
负责人:Donald H Burke
-
依托单位:
Determinates of anti-HIV nucleic acid aptamer potency and resistance
-
批准号:7879022
-
项目类别:
-
资助金额:$5.71万
-
财政年份:2009
-
负责人:Donald H Burke
-
依托单位:
Determinates of anti-HIV nucleic acid aptamer potency and resistance
-
批准号:7801719
-
项目类别:
-
资助金额:$3.93万
-
财政年份:2009
-
负责人:Donald H Burke
-
依托单位:
Determinates of anti-HIV nucleic acid aptamer potency and resistance
-
批准号:7418746
-
项目类别:
-
资助金额:$37.06万
-
财政年份:2008
-
负责人:Donald H Burke
-
依托单位:
Determinates of anti-HIV nucleic acid aptamer potency and resistance
-
批准号:8213487
-
项目类别:
-
资助金额:$43.12万
-
财政年份:2008
-
负责人:Donald H Burke
-
依托单位:
Gene Therapy for HIV Using Aptamers that Target Reverse Transcriptase
-
批准号:9293218
-
项目类别:
-
资助金额:$57.91万
-
财政年份:2008
-
负责人:Donald H Burke
-
依托单位:
Determinates of anti-HIV nucleic acid aptamer potency and resistance
-
批准号:7556790
-
项目类别:
-
资助金额:$41.38万
-
财政年份:2008
-
负责人:Donald H Burke
-
依托单位:
Gene Therapy for HIV Using Aptamers that Target Reverse Transcriptase
-
批准号:8789204
-
项目类别:
-
资助金额:$56.91万
-
财政年份:2008
-
负责人:Donald H Burke
-
依托单位:
Determinates of anti-HIV nucleic acid aptamer potency and resistance
-
批准号:7761216
-
项目类别:
-
资助金额:$43.46万
-
财政年份:2008
-
负责人:Donald H Burke
-
依托单位:
Determinates of anti-HIV nucleic acid aptamer potency and resistance
-
批准号:8035890
-
项目类别:
-
资助金额:$43.3万
-
财政年份:2008
-
负责人:Donald H Burke
-
依托单位:
RNA aptamers to inhibit natural and evolved RT variants
-
批准号:7024610
-
项目类别:
-
资助金额:$21.53万
-
财政年份:2005
-
负责人:Donald H Burke
-
依托单位:
RNA aptamers to inhibit natural and evolved RT variants
-
批准号:6893031
-
项目类别:
-
资助金额:$18.62万
-
财政年份:2005
-
负责人:Donald H Burke
-
依托单位:
RNA-PROTEIN INTERACTIONS
-
批准号:6170339
-
项目类别:
-
资助金额:$21.64万
-
财政年份:1999
-
负责人:Donald H Burke
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: